Publicaciones (23) Publicaciones en las que ha participado algún/a investigador/a

2017

  1. 11C-Methionine-PET in multiple myeloma: A combined study from two different institutions

    Theranostics, Vol. 7, Núm. 11, pp. 2956-2964

  2. 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging

    Tumor Biology, Vol. 39, Núm. 10, pp. 1-23

  3. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, Núm. 9, pp. 1575-1587

  4. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype

    Journal of Alzheimer's disease : JAD, Vol. 57, Núm. 2, pp. 447-459

  5. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

  6. Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine

    Journal of Medical Microbiology, Vol. 66, Núm. 7, pp. 946-958

  7. Emerging clinical issues and multivariate analyses in PET investigations

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 386-404

  8. Erratum to: The need of standardization and of large clinical studies in an emerging indication of [18F]FDG PET: the autoimmune encephalitis (European Journal of Nuclear Medicine and Molecular Imaging, (2017), 44, 3, (353-357), 10.1007/s00259-016-3589-9)

    European Journal of Nuclear Medicine and Molecular Imaging

  9. European regulations for the introduction of novel radiopharmaceuticals in the clinical setting

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 2, pp. 135-144

  10. Ionizing radiation received by patients with osteosarcoma during intra-arterial chemotherapy treatment

    Anales del sistema sanitario de Navarra, Vol. 40, Núm. 1, pp. 85-92

  11. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients

    Journal of Vascular and Interventional Radiology, Vol. 28, Núm. 11, pp. 1536-1542

  12. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: Is PET imaging of pancreatic beta cell mass feasible?

    Quarterly Journal of Nuclear Medicine and Molecular Imaging, Vol. 61, Núm. 4, pp. 447-455

  13. MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer

    European Radiology, Vol. 27, Núm. 8, pp. 3190-3198

  14. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury

    Journal of Translational Medicine, Vol. 15, Núm. 1

  15. Nuevos tiempos para la neuroimagen de Medicina Nuclear en España: ¿de dónde partimos?

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 4, pp. 219-226

  16. Nuevos tiempos para los grupos de trabajo de la SEMNIM

    Revista Espanola de Medicina Nuclear e Imagen Molecular

  17. PET biomarkers: Use of imaging techniques in Alzheimer disease and neurodegeneration clinical diagnosis

    Neurologia, Vol. 32, Núm. 5, pp. 275-277

  18. Performance characteristics of the whole-body discovery IQ PET/CT system

    Journal of Nuclear Medicine, Vol. 58, Núm. 7, pp. 1155-1161

  19. Position statement on radiopharmaceutical production for clinical trials

    EJNMMI Radiopharmacy and Chemistry, Vol. 2, Núm. 1

  20. Procedimientos recomendados de dosimetría de pacientes en tratamientos de hipertiroidismo con I-131: Grupo de trabajo de dosis tras la administración de radiofármacos de la S.E.F.M.

    Revista de Física Médica, Vol. 18, Núm. 2, pp. 143-176